SK bioscience’s World-First Cell Culture-Based Quadrivalent Influenza Vaccine Is Approved in Chile

Home / News / SK bioscience’s World-First Cell Culture-Based Quadrivalent Influenza Vaccine Is Approved in Chile


https://www.skbioscience.com/en/news/news_01_01?mode=view&id=165&



            
                
                                            Recent NewsRecommended Flu Vaccines for Older Adults
New RSV treatment for infants could impact this year’s flu and virus season in Virginia
Australia’s flu season is hitting kids the hardest. What does this mean for Canada?
What to Know About Guillain-Barré Syndrome After Peru Outbreak
Thanks to viral megatests, a ‘cold’ may not be so common anymore
			
	
		
	



	
		About Us
	
	
		
	



	
		In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.

In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

	



	
	Read More


        

        
                    
                
                    Related Health Education
                                        
                        
                            
                                
                                    New RSV treatment for infants could impact this year’s flu and virus season in Virginia                                
                            
                        
                                        
                        
                            
                                
                                    Australia’s flu season is hitting kids the hardest. What does this mean for Canada?                                
                            
                        
                                        
                        
                            
                                
                                    What to Know About Guillain-Barré Syndrome After Peru Outbreak                                
                            
                        
                                        
                        
                            
                                
                                    Thanks to viral megatests, a ‘cold’ may not be so common anymore                                
                            
                        
                                        
                        
                            
                                
                                    WHO reports dozens of babies sickened by deadly viral infections

Related Posts

SK bioscience’s World-First Cell Culture-Based Quadrivalent Influenza Vaccine Is Approved in Chile

Related Health Education